Privi Speciality Chemicals Ltd Q1 FY2025 Concall Summary

Key Takeaways

• Record margins, confident tone: EBITDA margins hit historic peaks, and management has "very, very fair visibility" of sustaining them for at least the next year, driven by internal efficiencies and full capacity utilization.
• Volume growth accelerating: The company expects ~20% volume growth for FY25, potentially inching closer to 25%, as flagship products approach 100% capacity utilization and new products ramp up.
• Operating leverage from process innovation: Converting batch processes to continuous ones has steadily increased capacity without major new equipment, while a new efficient boiler and solar power are structurally lowering per-unit costs.
• Prigiv JV nears commercialization: The greenfield JV with Givaudan is at an advanced stage and expected to start commercial production by Q3 or Q4 FY25, adding over 40 products exclusively.
• What to watch next quarter: Whether the Privi Fine Sciences acquisition clears shareholder approval on 12th August and what integration details management then shares, plus the trajectory of camphor prices as the main Indian season begins.

Margin Structure & Sustainability

• Historic peak with visibility: EBITDA margins are at their highest level, and management states they are "there to stay" for FY25 with fair visibility for the next 2-3 quarters. Raw material arrangements are back-to-back, giving clarity on input costs, while spot market prices for finished goods are rising due to raw material shortages, helping realization.
• Structural cost takeout: A new, highly efficient boiler reduced steam cost per kg, heat capture equipment was installed, and solar power now supplies the largest utility at roughly ₹3.5/unit cheaper than grid power. These are permanent shifts in the cost base, not cyclical relief.
• Other expenses halved: Other expenses per ton dropped from ~₹70,000 to ~₹50,000 over 3-4 years through solar adoption, better freight negotiation post-Red Sea crisis, and novel technologies. Freight costs specifically improved in Q1 as forwarder contracts were renegotiated after the Red Sea peak.
• Renewable elements uplift: When buying crude sulphate turpentine from European sources, roughly 20% of material not usable for aroma chemicals can be sold as solvent at ~₹100, but processing it into renewable elements increases the margin significantly.
• FY26 clarity by December: Management will have a better position on whether margins can continue into FY26 around December, when calendar year 2025 contracts are finalized and raw material inputs become clearer. If the global outlook holds, margins can continue.

Iyer: "these margins are there to stay and we are very confident of our margin levels as we talk about at least for the year 24-25 that we are in"

Volume Growth & Capacity

• 20-25% volume growth target: Management expects overall volume growth upwards of 20% for FY25, potentially reaching 25% if calendar year 2025 contracts are strong. Clarity exists for the next four quarters.
• Flagship products near full: Dihydromyrcenol, Amber Fleur, Pine Oil, and Terpineol are targeted to sell at 100% capacity in FY25 to hold market share and propel growth. Camphor and Galaxmusk are also expected to reach near-100% utilization going forward.
• Process innovation as capacity lever: Over the last 4-5 years, converting batch processes to continuous ones has steadily increased output from the same equipment. In a continuous system, the reactor does not cool down between batches, extracting more throughput without major capex.
• Three demand drivers: Volume growth is fueled by (1) growing demand from multinational FMCG companies where even 2% growth creates substantial ingredient pull, (2) customer comfort with Privi's sustainability and zero liquid discharge credentials, and (3) new product introductions reaching 85-90% capacity utilization.
• Market share gains: The industry is growing at roughly 5-6%, and Privi is gaining share from competitors on better quality, service, on-time delivery, and logistics.

Patil: "...if I am operating on a batch basis, so batch basis versus, let us say, I convert those into continuous basis. So, in a continuous system, at the end of every batch, the reactor cools down, then I again hit the reactor and all that. Against that, if I am doing everything on a continuous basis, then I'm able to extract more output from the same set of equipment..."

New Products & Projects

• Galaxmusk: Launched last year with contracts and permissions arriving mid-year, sales are now higher YoY with good order booking and spot markets absorbing product. Expected to approach 100% capacity utilization.
• Camphor: Backward integration has already started adding margins. The main Indian season begins in July, when domestic consumption surges. Prices have been on an increasing trend for the last 1-1.5 months and are expected to continue rising, benefiting all Indian manufacturers.
• Prionyl: Making inroads with blenders and capacities slowly increasing, but as a specialty product it will take time to reach full optimal capacity. Momentum is expected to continue.
• Menthol project: Produced from side streams of CST and GTO processing, so it adds value to overall profitability rather than standing alone. No specific timeline was given for returns.
• Prigiv JV: The greenfield expansion with Givaudan in Mahad is at an advanced implementation stage, expected to commercialize by Q3 FY25, more likely Q4. It will manufacture over 40 products exclusively and add to growth contribution, though not a major thrust initially.
• US FDA: The company is one more step along in the process and is poised to obtain approval by this year-end.

Competitive Position & Geography

• Sustainability as a moat: Management cited zero liquid discharge as the single factor that beats competitors, a credential that is increasingly important to multinational FMCG customers when selecting ingredient suppliers.
• Geographic balance: India contributed 32% of revenue in Q1 versus a normal average of roughly 30%, with Europe at roughly 33%. The spread is even, with no single territory overshooting.
• Latin America progress: Slight growth was witnessed this quarter versus earlier quarters, achieved by selling through the Privi US subsidiary to customers with better payment terms.

Patil: "...one factor that I think we beat everybody is our sustainability, and we bring zero liquid..."

Acquisitions & Investments

• Privi Fine Sciences acquisition: Announced last month, the acquisition is still in process with shareholder approval sought via postal ballot due by 12th August. An integration plan exists to optimize costs and work on synergies, but management declined to share details or quantify top-line and margin impact before shareholder mandate.
• Solar power SPV: The company invested 26% equity in a Special Purpose Vehicle for solar power, with debt sitting on the SPV. It is already generating savings of roughly ₹2 crores per quarter.

Guidance & Commitments

Key Metrics